Our Founders

Stanley Satz, Ph.D., Chief Science Officer & Chairman

A radiation physicist with more than 40 years of experience and an expert in the development of radiopharmaceuticals for tumor targeted radiation therapy, Satz’s coordination chemistry studies have enabled the synthesis of novel small molecules that have been translated from pre-clinical to clinical use for pediatric diseases and breast cancer.

Roseanne Satz, Chief Executive Officer

With over 20 years of leadership in radiopharmaceuticals, Ms. Satz's management, regulatory, and production efforts have resulted in multiple FDA approvals. Her network of clinicians, scientists, research organizations, and manufacturing partners allows AIP to efficiently develop, launch, and supply its pharmaceutical candidates.

Scientific & Clinical Advisors

AIP has several word renowned collaborators, scientists, business leaders, and clinical advisors that support our mission.

© 2018 Advanced Innovative Partners, Inc., U.S.A.

Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AIP Inc., its subsidiaries or affiliates. No use of any AIP trademark, trade name, or trade dress in this site may be made without the prior written authorization of AIP Inc., except to identify the product or services of the company.

  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon